BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 3859259)

  • 1. Non-Hodgkin's lymphoma involving the central nervous system.
    Wolf MM; Olver IN; Ding JC; Cooper IA; Liew KH; Madigan JP
    Aust N Z J Med; 1985 Feb; 15(1):16-21. PubMed ID: 3859259
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Central nervous system complications of non-Hodgkin's lymphoma. The potential role for prophylactic therapy.
    Young RC; Howser DM; Anderson T; Fisher RI; Jaffe E; DeVita VT
    Am J Med; 1979 Mar; 66(3):435-43. PubMed ID: 433950
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CNS involvement in the non-Hodgkin's lymphomas.
    Levitt LJ; Dawson DM; Rosenthal DS; Moloney WC
    Cancer; 1980 Feb; 45(3):545-52. PubMed ID: 6986199
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Central nervous system relapse in unfavourable-histology non-Hodgkin's lymphoma: is prophylaxis indicated?
    Johnson GJ; Oken MM; Anderson JR; O'Connell MJ; Glick JH
    Lancet; 1984 Sep; 2(8404):685-7. PubMed ID: 6147703
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-Hodgkin's lymphoma in children.
    Pinkel D; Johnson W; Aur RJ
    Br J Cancer Suppl; 1975 Mar; 2():298-323. PubMed ID: 1101924
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CNS involvement by non-Hodgkin's lymphoma. Response to a standard therapeutic protocol.
    Raz I; Siegal T; Siegal T; Polliack A
    Arch Neurol; 1984 Nov; 41(11):1167-71. PubMed ID: 6487100
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Involvement of the central nervous system by non-Hodgkin's lymphoma: the Southwest Oncology Group experience.
    Herman TS; Hammond N; Jones SE; Butler JJ; Byrne GE; McKelvey EM
    Cancer; 1979 Jan; 43(1):390-7. PubMed ID: 761173
    [No Abstract]   [Full Text] [Related]  

  • 8. Involvement of the central nervous system in non-Hodgkin's lymphoma.
    Law IP; Dick FR; Blom J; Bergevin PR
    Cancer; 1975 Jul; 36(1):225-31. PubMed ID: 1106832
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathology with clinical correlations of primary central nervous system non-Hodgkin's lymphoma. The Massachusetts General Hospital experience 1958-1989.
    Miller DC; Hochberg FH; Harris NL; Gruber ML; Louis DN; Cohen H
    Cancer; 1994 Aug; 74(4):1383-97. PubMed ID: 8055462
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Central nervous system metastases from non-Hodgkin's lymphoma: treatment and prophylaxis.
    Recht L; Straus DJ; Cirrincione C; Thaler HT; Posner JB
    Am J Med; 1988 Mar; 84(3 Pt 1):425-35. PubMed ID: 3348245
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isolated central nervous system relapse in aggressive non-Hodgkin's lymphoma: the Bologna experience.
    Zinzani PL; Magagnoli M; Frezza G; Prologo G; Gherlinzoni F; Bendandi M; Albertini P; Babini L; D'Alessandro R; Tura S
    Leuk Lymphoma; 1999 Feb; 32(5-6):571-6. PubMed ID: 10048430
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Secondary involvement of the central nervous system in malignant non-Hodgkin's lymphoma. A study of 30 cases in a series of 498 patients.
    Hoerni-Simon G; Suchaud JP; Eghbali H; Coindre JM; Hoerni B
    Oncology; 1987; 44(2):98-101. PubMed ID: 3574856
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination chemotherapy for advanced non-Hodgkin's lymphomas other than diffuse histiocytic or undifferentiated histologies.
    Anderson KC; Skarin AT; Rosenthal DS; MacIntyre JM; Pinkus GS; Case DC; Leonard RC; Canellos GP
    Cancer Treat Rep; 1984 Nov; 68(11):1343-50. PubMed ID: 6209007
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hematologic neoplasia and the central nervous system.
    Sham RL; Phatak PD; Kouides PA; Janas JA; Marder VJ
    Am J Hematol; 1999 Dec; 62(4):234-8. PubMed ID: 10589079
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Non-Hodgkin's malignant lymphoma with central nervous involvement--report of 7 cases].
    Nagata T; Kobayashi A; Aiba K; Yokoyama K; Ikeda K; Kobayashi T; Chiene T; Kuraishi Y; Meguro S; Ichiba K; Abe M
    Gan No Rinsho; 1983 Jun; 29(7):838-42. PubMed ID: 6876452
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pediatric Oncology Group experience with modified LSA2-L2 therapy in 107 children with non-Hodgkin's lymphoma (Burkitt's lymphoma excluded).
    Sullivan MP; Boyett J; Pullen J; Crist W; Doering EJ; Trueworthy R; Hvizdala E; Ruymann F; Steuber CP
    Cancer; 1985 Jan; 55(2):323-36. PubMed ID: 3880656
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Central nervous system involvement in haematological malignancies.
    Sheehan T; Cuthbert RJ; Parker AC
    Clin Lab Haematol; 1989; 11(4):331-8. PubMed ID: 2605874
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-Hodgkin's lymphoma: patterns of relapse from complete remission after combination chemotherapy.
    Schein PS; Chabner BA; Canellos GP; Young RC; DeVita VT
    Cancer; 1975 Feb; 35(2):354-7. PubMed ID: 1089470
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CNS involvement in children with newly diagnosed non-Hodgkin's lymphoma.
    Sandlund JT; Murphy SB; Santana VM; Behm F; Jones D; Berard CW; Furman WL; Ribeiro R; Crist WM; Greenwald C; Chen G; Walter A; Pui CH
    J Clin Oncol; 2000 Aug; 18(16):3018-24. PubMed ID: 10944136
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Results of combination chemotherapy of non-Hodgkin's lymphoma.
    Schein PS; Chabner BA; Canellos GP; Young RD; Berard C; DeVita VT
    Br J Cancer Suppl; 1975 Mar; 2():465-73. PubMed ID: 1101932
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.